Study to Assess the Safety and Bioeffect of REGN1033 (SAR391786)

NCT01910220 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

125

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: REGN1033 (SAR391786)
OTHER: placebo

Sponsor

Regeneron Pharmaceuticals

Collaborators

[object Object]